Q3 2026 results

MetricResultChange
Net Revenue$11.4 billion+5.5% in dollar terms
Adjusted Diluted EPS$2.36+5.4%
Adjusted Operating Income MarginAlmost 45%+130 basis points
IQOS HTU Shipments41.5 billion unitsNot stated
VEEV Shipment Growth62%Not stated

Guidance and outlook

  • Full-year organic net revenue growth: 5% to 7%.
  • Full-year organic operating income growth: 7% to 9%.
  • Full-year currency-neutral adjusted diluted EPS growth: 7.5% to 9.5%.
  • Full-year adjusted diluted EPS in dollar terms: $8.29 to $8.44.
  • Q4 U.S. adjusted OCI: Around 0 or slightly negative.

How management sounded

Positive (+6 on our -10 to +10 scale). Management delivered record quarterly EPS and strong organic growth while navigating geopolitical cost pressures and significant strategic investments in the U.S. Management sounded more upbeat than on 8% of the 190 calls we cover; most companies sound positive on their own calls, so the comparison says more than the label.

Q&A summary

Guidance and Costs

Asked: Bonnie Herzog from Goldman Sachs asked why the company is guiding to the lower half of the range despite strong Q3 results.

Answer: Management cited cost pressures from geopolitical tensions in the Middle East and Ukraine, alongside exceptional U.S. investment for ZYN portfolio expansion.

ZYN Strategy

Asked: Bonnie Herzog from Goldman Sachs asked about the performance of ZYN innovations and the impact of the 20-pouch transition.

Answer: Management stated initial results are positive and the 20-pouch transition is a value proposition improvement that will impact Q4 revenue but drive long-term growth.

Inflation and Offsets

Asked: Matt Smith from Stifel asked how the company plans to offset inflationary impacts.

Answer: Management highlighted the resilience of their supply chain, strong pricing power, and margin expansion as key buffers against volatile energy and input costs.

Germany Taxation

Asked: Andrei Andon-Ionita from Jefferies asked about the impact of sharp excise tax increases in Germany.

Answer: Management acknowledged the challenge but noted they are well-positioned with strong brands like Marlboro and continued IQOS growth to compete effectively.

What to watch before the next call

  • Impact of the 20-pouch ZYN transition on Q4 U.S. profitability.
  • Persistence of energy-related inflation and geopolitical disruptions in the Middle East and Ukraine.
  • Performance of new ZYN variants and portfolio expansion in the U.S. market.